قالب وردپرس درنا توس
Home / Health / Regeneron stops recruiting severe COVID-19 patients for antibody drug trials

Regeneron stops recruiting severe COVID-19 patients for antibody drug trials



Regeneron Pharmaceuticals has suspended research in patients with severe COVID-19 in a trial of antibody cocktail therapy given to President Trump earlier this month. The decision was due to a potential safety hazard.

The drug maker on Friday Said After the independent monitoring committee observed “there are currently potential safety signals and unfavorable risk/benefit characteristics”, the company suspended the enrollment of hospitalized COVID-19 patients requiring high-flow oxygen or mechanical ventilation.


Our country is engaged in a historic battle against the coronavirus.Add change to your Facebook Either Twitter Feed to always follow the news.


The recruitment of patients in this category will be suspended until other data is collected and analyzed.

The trial will continue to test the antibody mixture in hospitalized patients who require little or no additional oxygen. Other trials involving patients with mild or moderate disease can also continue.

The drug showed encouraging results. Regeneron said on Wednesday that early data showed that the therapy reduced the number of medical visits related to COVID-1

9 by 57%.

Regeneron requested emergency approval from the Food and Drug Administration earlier this month and stated that it will provide free doses to the American people. The drugmaker said it may provide enough doses to 300,000 people in the next few months.

On Monday, Eli Lilly stopped its monoclonal antibody research on hospitalized patients because the study found that the treatment did not benefit COVID-19 patients.

Earlier this month, at the request of compassionate use, Trump was provided with an 8-gram dose of an experimental treatment drug for Regeneron, which he believed could help him overcome the disease.


You need to understand the contents of the coronavirus immediately

How to prepare for the third wave of coronavirus and winter

The spike in the coronavirus case is “more than just testing features”, testing CZAR means the opposite

How to prepare for the third wave of coronavirus and winter

In the next two months, wearing a mask may save more than 100,000 lives: new research

Smart sensors may be a high-tech solution to social problems in the office





Source link